There is one clinical trial.

Clinical Trials

1 Relative Bioavailability of Rosuvastatin (Part 1) and Dabigatran (Part 2) Given Alone and Together With BI 1323495 in Healthy Male Subjects (Open, Single-dose, Randomised, Two-period Crossover Design in Each Trial Part)

The main objectives of this trial are to investigate the relative bioavailabilities of rosuvastatin (Reference 1, Part 1) and dabigatran (Reference 2, Part 2) given alone and together with BI 1323495 (Test 1, Test 2) following oral administration.

NCT04257032 Healthy Drug: Rosuvastatin Drug: Rosuvastatin + BI 1323495 Drug: Dabigatran etexilate Drug: Dabigatran etexilate + BI 1323495

No related HPO nodes (Using clinical trials)